US Stock MarketDetailed Quotes

NKTR Nektar Therapeutics

Watchlist
  • 1.1100
  • -0.1000-8.26%
Close Aug 9 16:00 ET
  • 1.1100
  • 0.00000.00%
Post 16:02 ET
204.26MMarket Cap-1233P/E (TTM)

Nektar Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Nektar Therapeutics Earnings Date

Currency: USD

Period

Q2 FY2024 Estimates

Aug 8, 2024

Revenue(YoY)

17.55M

-14.41%
EPS(YoY)

-0.20

+24.45%
Analyst Rating

Hold

Aug 9, 2024

Nektar Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 19.903M--
--2024/Q3-- / 19.542M--
Aug 8, 20242024/Q223.489M / 17.545M--
May 9, 20242024/Q121.639M / 15.342M--
Mar 4, 20242023/Q423.885M / 21.368M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 19.903M--
--2024/Q3-- / 19.542M--
Aug 8, 20242024/Q223.489M / 17.545M--
May 9, 20242024/Q121.639M / 15.342M--
Mar 4, 20242023/Q423.885M / 21.368M--

Unlock Free Earnings Estimates

Nektar Therapeutics Earnings Reports

  • Nektar Therapeutics | 10-Q: Quarterly report

    14:07 ET

  • Nektar Therapeutics | 10-Q: Q1 2024 Earnings Report

    May 10 14:13 ET

  • Nektar Therapeutics | 10-K: FY2023 Annual Report

    Mar 5 17:16 ET

  • Nektar Therapeutics: Q3 2023 Earnings Report

    Nov 7, 2023 17:54 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Aug 9, 2024

    Hold

    • Buy

      33.33%

    • Hold

      33.33%

    • Sell

      33.33%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg